Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Nearly beaten to death, months later his mother is shot dead in the kitchen of their home! Years of horrific child abuse so awful that a polygraph test is administered to reveal the truth and the court orders the records sealed! Years later working as a Bounty Hunter and Strong Arm Collector he makes a decision so big that it changes his life forever! As seen on National Television
Honeywell (NYSE:HON) today announced the next generation of smart building technology, Command and Control Suite, which turns complex facility data into recommendations and easy-to-implement changes that help boost business outcomes — lowering costs, minimizing risk and reducing downtime.
By combining intelligent automation, advanced analytics and visualization with the simplified user experience of today‘s home and mobile electronics, Command and Control Suite links building automation and the enterprise. It can provide a holistic view of a connected building‘s video feeds, access control and fire alarms, for example, and pull in relevant information from human resource applications. Integrating data from these disparate systems could help security personnel track occupants and make sure they exit the facility in the event of an evacuation, improving employee safety.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7525451-honeywell-command-and-control-suite/
Adlens, the global leader in adjustable focus eyewear, has launched its ground-breaking adjustable prescription eyewear ‘AdlensFocuss™’, the greatest advancement in optics in more than 50 years.
Vision inevitably changes with age and people often need different strength glasses to see at near, intermediate and far distances. Progressive lenses are an option but they have a restricted usable lens area. A GFK Roper Study has shown one-third of wearers say they have trouble adjusting to them with seven to eight percent of wearers saying they cannot adjust to them at all.
AdlensFocuss provides the benefits of a single vision lens – full frame viewing area – with the best features of a progressive lens – the ability to see at different distances. They are prescription glasses with proprietary technology; a unique flexible membrane that allows the power to be adjusted by simply turning small dials on the inside of the frames. AdlensFocuss lenses offer at least four times more viewing area than traditional progressive lenses and come encased in a fashion-forward frame from award-winning designer Blake Kuwahara.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7544851-adlensfocuss-optics-technology/
Blu® Homes, Inc. (“Blu”), America’s leading provider of premium prefab homes, today announced the newest model in its 2014 product line, the Breeze Aire. This exciting new model offers a spacious layout, high-end finishes, and standard floor plan combinations that offer this beautiful home to clients across the United States in as little as seven months, as well as highly custom choices for those who prefer to make detailed engineering changes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64410-blu-homes-new-model-updated-2014-product-line-breeze-aire
According to the 2016 Franchise Business Economic Outlook report, employment growth in the franchise sector will continue to outpace the growth of employment in all businesses economy-wide, as it has in each of the last six years. The franchise industry is set to grow by 1.7 percent in 2016 which added over 13,000 new franchise businesses, generating over $900 billion in economic output and 278,000 new jobs in 2015.
Kumon, the world’s largest education franchise, continues to flourish as it surpassed company milestones in 2015 with nearly 300,000 students enrolled in its math and reading programs nationwide.
“Many of our 1,500 franchise owners opened Kumon centers after experiencing first-hand how Kumon gave their own children an academic advantage that put them ahead of their peers,” says Larry Lambert, vice president of franchise recruitment at Kumon North America. “Kumon is helping thousands of aspiring small business owners transform their lives with a career that rewards them and changes the lives of youth every day.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7720256-kumon-franchise/
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced the U.S. Food and Drug Administration (FDA) approval and launch of the Cochlear™ Nucleus® Hybrid Implant System, a revolutionary new hybrid hearing solution that helps people who may hear a little but are still missing a lot, even with their hearing aids. The Nucleus Hybrid System is a unique combination of proven solutions, which allows people to get back what they've been missing by amplifying the low-pitched hearing a person does have while restoring access to the high-pitched hearing they've lost. People who are candidates for the technology no longer have to worry about straining to hear with their hearing aids as the Nucleus Hybrid System will allow them to maximize their hearing in all frequencies.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7150651-cochlear-fda-approval-u-s-launch-cochlear-nucleus-hybrid-implant-system
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Today, GENYOUth announced the launch of Fuel Up to Play 60 en español, an evolution of its national flagship program. The program encourages Spanish-speaking communities nationwide to live healthier lifestyles through good nutrition and physical activity. Fuel Up to Play 60 launched a redesigned website (FuelUpToPlay60.com) that provides Spanish-language content and materials, extending the reach and access of the program to students, teachers and families across the country. Several organizations have supported the effort, including the PepsiCo Foundation, which has provided a previously announced grant of $550,000 to develop Spanish-language materials and resources. In addition the PepsiCo Foundation will provide another $100,000 for mini-grants for health and wellness activities and programming within Los Angeles Unified School District and Miami-Dade County Public Schools.
Fuel Up to Play 60, a program founded by the National Football League (NFL) and National Dairy Council (NDC), is designed to engage and empower youth to take action for their own health by implementing long-term, positive nutrition and physical activity changes for themselves, their schools and their communities. Studies show that physical fitness may benefit brain health and academic performance, suggesting active kids may do better. However, only 1 in 3 kids are active every day, potentially leaving many at a disadvantage inside and outside of the classroom.
To view the multimedia release go to:
http://www.multivu.com/players/English/7646551-fuel-up-to-play-60/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Kia Motors America (KMA) today unveiled the all-new 2017 Sportage at the Los Angeles Auto Show. The fourth-generation Sportage, KMA’s longest-running nameplate, wraps stunning contemporary design around a structure that is both stiffer and more spacious than before. Advanced driver assistance technologies, significant suspension and steering improvements, and available intelligent AWD vastly improve the Sportage’s driving dynamics while premium materials and world-class craftsmanship create a class-up experience in an otherwise utilitarian segment.
“Simply put, the Sportage is a breed apart in the compact CUV segment,” said Orth Hedrick, vice president, product planning KMA. “Instead of bland utility, the Sportage combines distinctly European and sporty styling with thoughtful design and functionality, including innovative packaging, premium materials, a turbocharged engine and surprising features. Sales of compact CUVs are on a sharply upward trajectory, and the all-new 2017 Sportage hits the sweet spot by providing an alternative for those seeking to express themselves with a vehicle that’s versatile enough to suit their unique lifestyle.”
The all-new Sportage’s roomier, more luxurious cabin features an impressive level of craftsmanship, with high-quality, soft-touch materials and a range of technologies improving overall comfort, convenience, and connectivity. Updates to the drivetrain provide enhanced efficiency and performance, while changes to the suspension deliver better ride and handling. Like the outgoing model, the all-new Sportage will be built at Kia’s production facility in Gwangju, Korea, and be available in three distinct trim levels (LX, EX, SX Turbo) when it goes on sale next year. Pricing will be announced closer to the Sportage’s on-sale date.
To view the multimedia release go to:
http://www.multivu.com/players/English/7436354-2017-kia-sportage-l-a-auto-show-debut/
It's longer – and deeper – than any other train tunnel in the world. Sunday 11 December 2016 sees the entering into service of the Gotthard Base Tunnel. This pioneering project will enable passengers to speed under the Alps in some 17 minutes. The dual-track tunnel will bring northern and southern Switzerland closer together, and cut travel time between neighbouring countries. It will permit passengers from near and far to spend more time at their destination, discovering the many delights of Switzerland north and south of the Alps.
Switzerland already possesses the densest public transport network on the planet. And over the years it has increased its impressive lead over other nations. June 2016 saw the festive inauguration of the Gotthard Base Tunnel – a 17-year pioneering project which extends for 57 kilometres down to a maximum depth of 2300 metres under the Gotthard massif. The Swiss Federal Railways (SBB) have now finished subjecting the tunnel to exhaustive safety and technical tests. On Sunday 11 December – the day on which Switzerland's public transport network changes its annual timetable nationwide – the Gotthard Base Tunnel will enter into scheduled service.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7988951-opening-gotthard-base-tunnel-longest-train/
